Inventor · disambiguated record

Pachamuthu Kandasamy

Also filed as: KANDASAMY PACHAMUTHU

29 granted patents·22 pending applications·231 citations·filing 2012–2025

97Inventor score

Technology areasC12N A61K C07H C07C C12Y

Files withALNYLAM PHARMACEUTICALS INC27 WAVE LIFE SCIENCES LTD20 KANDASAMY PACHAMUTHU1 MAGUIRE ABBIE MADELINE1 MONIAN PRASHANT1

Top patents by PatentIndex Score

51 records

0198US11679158B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Jun 20, 2023·7 cites·13 claims
0298US11633479B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·11 cites·24 claims
0398US11633480B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·11 cites·28 claims
0498US11612657B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Mar 28, 2023·9 cites·30 claims
0598US11590229B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Feb 28, 2023·11 cites·29 claims
0698US11382979B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Jul 12, 2022·18 cites·30 claims
0798US11246933B1Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Feb 15, 2022·30 cites·28 claims
0898US10369226B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Aug 6, 2019·25 cites·42 claims
0998US9061063B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Jun 23, 2015·41 cites·32 claims
1096US11071784B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Jul 27, 2021·5 cites·1 claims
1195US11400158B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Aug 2, 2022·1 cites·30 claims
1293US10086081B2Carbohydrate conjugated RNA agents and process for their preparationALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Oct 2, 2018·11 cites·10 claims
1392US12364762B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Jul 22, 2025·0 cites·14 claims
1492US12350338B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Jul 8, 2025·0 cites·14 claims
1592US12343398B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·0 cites·30 claims
1692US12239709B2Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Mar 4, 2025·0 cites·28 claims
1792US11739325B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Aug 29, 2023·12 cites·23 claims
1891US12428442B2Compounds, compositions and methods for synthesisWAVE LIFE SCIENCES LTD·Filed 2023·Granted Sep 30, 2025·1 cites·21 claims
1991US11718638B2Compounds, compositions and methods for synthesisWAVE LIFE SCIENCES LTD·Filed 2018·Granted Aug 8, 2023·10 cites·20 claims
2091US2024398956A1Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
2190US11873316B2Compositions and methods for phosphoramidite and oligonucleotide synthesisWAVE LIFE SCIENCES LTD·Filed 2017·Granted Jan 16, 2024·10 cites·18 claims
2289US11608355B2Technologies for oligonucleotide preparationWAVE LIFE SCIENCES LTD·Filed 2018·Granted Mar 21, 2023·10 cites·25 claims
2388US2023256098A1Biodegradable lipids for the delivery of active agentsALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
2485US10808246B2Oligonucleotide-ligand conjugates and process for their preparationALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Oct 20, 2020·6 cites·9 claims
2585US2025236871A1Multi-targeted single entity conjugatesALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
2685US2024252653A1Carbohydrate conjugated rna agents and process for their preparationALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
2782US2025075208A1Oligonucleotide-ligand conjugates and process for their preparationALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
2879US11944687B2Carbohydrate conjugate RNA agents and process for their preparationALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 2, 2024·0 cites·4 claims
2978US12391942B2Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2019·Granted Aug 19, 2025·2 cites·32 claims
3075US12473321B2Compositions and methods for phosphoramidite and oligonucleotide synthesisWAVE LIFE SCIENCES LTD·Filed 2023·Granted Nov 18, 2025·0 cites·10 claims
3175US2025066775A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
3274US12435105B2Technologies for oligonucleotide preparationWAVE LIFE SCIENCES LTD·Filed 2023·Granted Oct 7, 2025·0 cites·29 claims
3374US12221607B2Multi-targeted single entity conjugatesALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Feb 11, 2025·0 cites·24 claims
3472US12173288B2Oligonucleotide-ligand conjugates and process for their preparationALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Dec 24, 2024·0 cites·6 claims
3570US2024279658A1Double stranded oligonucleotide compositions and methods relating theretoWAVE LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
3665US2019134206A1Carbohydrate conjugated rna agents and process for their preparationALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
3763US11053495B2Multi-targeted single entity conjugatesALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Jul 6, 2021·0 cites·13 claims
3863US2025262235A1Oligonucleotide compositions and methods relating theretoWAVE LIFE SCIENCES LTD·Filed 2023·Application pending·0 cites
3963US2024026358A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
4062US2025302995A1Oligonucleotide compositions and methods thereofSHIVALILA CHIKDU SHAKTI·Filed 2023·Application pending·0 cites
4160US2025154190A1Stereoselective technologies for chiral compoundsWAVE LIFE SCIENCES LTD·Filed 2023·Application pending·0 cites
4259US2023392137A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
4359US2025135036A1Compositions for editing mecp2 transcripts and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
4459US2025382617A1Double stranded oligonucleotide compositions for rna interference and methods relating theretoWAVE LIFE SCIENCES LTD·Filed 2025·Application pending·0 cites
4559US2025333740A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
4656US2023203484A1Double stranded oligonucleotide compositions and methods relating theretoWAVE LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
4754US2023295619A1Oligonucleotide compositions and methods thereofMAGUIRE ABBIE MADELINE·Filed 2021·Application pending·0 cites
4850US2023329201A1Cells and non-human animals engineered to express adar1 and uses thereofWAVE LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
4949US2023220384A1Oligonucleotide compositions and methods of use thereofMONIAN PRASHANT·Filed 2020·Application pending·0 cites
5048US2023203087A1Oligonucleotide compositions and methods thereofKANDASAMY PACHAMUTHU·Filed 2021·Application pending·0 cites

Showing the top 50 of 51 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Pachamuthu Kandasamy files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →